This idea comes directly from the Start-up Dayewhich hopes to facilitate STI screening (Sexually transmitted infections) for women. A promising invention that would allow those interested to avoid the logistical or psychological pitfalls of traditional screening. The buffer is currently in the test phase and is based on the PCR technique (Polymerase chain reaction), very effective for detecting pathogenic genetic material.
A technological leap forward for women’s health
Daye explains that many women at the time of screening with “both practical and emotional barriers to testing, including difficulty making appointments, fear and embarrassment.” Make it at home would then radically change this experience, which is sometimes complex to live.
While these tests are typically performed with a swab or speculum, using a tampon could allow for vaginal sampling wider and more complete.
A non-invasive solution, which is currently in clinical trials in the UK and Italy. This is done in collaboration with Lindus health with 375 patients. The idea of this testing phase is to determine the effectiveness and acceptance of the product.
More than just a tampon: a screening platform
Thanks to the PCR test, this buffer is detectable The most common sexually transmitted diseases : gonorrhea, chlamydia, mycoplasma, trichomonas and ureaplasma. Ultimately, the company would like to expand its scope to include the detection of human papillomavirus (HPV), genital herpes and bacterial streptococcal B infections.
The stamp costs at the moment £99 (approx. 113 euros) and will be sent by post. The patient carries out the manipulations herself and then returns the device to the laboratory. A few days later, the results can be viewed via an application. It is also possible to complete the process by booking a consultation with a nurse for an additional cost of £29 (33 euros). If one of the tests is positive, the user will always receive a credit A call from Daye to advise you on your care procedures.
We can certainly welcome this approach, even if the price is currently quite high. This is viewed rather positively by health professionals, although some remain rather shy, such as the British Association for Sexual Health and HIV (Bashh). In fact, the institution fears that the generalization of the diagnosis of certain organisms (particularly ureaplasmas) will lead to aggravation excessive attitude Antibiotic treatments. A phenomenon that could lead to this in the long term Antibiotic resistance Population.
- The start-up Daye has developed a tampon that can detect sexually transmitted diseases and that women can administer themselves at home.
- This is currently being tested in the UK and Italy.
- Ultimately, the company wants to expand its screening capabilities to other diseases with potentially serious consequences.
]
